US Stock Market Move | Most of the Chinese pharmaceutical stocks rose, BEIGENE (ONC.US) by over 9%
Most Chinese pharmaceutical stocks are up, as of press time, BeiGene's shares surged more than 9%.
On Tuesday, most of the Chinese pharmaceutical stocks rose. As of press time, BeiGene (ONC.US) rose by over 9%, HutchMed (HCM.US) rose by over 4%; and Zai Lab (ZLAB.US) dipped slightly by 0.08%. In terms of news, BeiGene CEO John Oyler mentioned that, according to US Generally Accepted Accounting Principles, the company is expected to achieve a positive operating profit for the full year of 2025 (meaning that operating income will exceed the sum of operating costs, sales expenses, management expenses, and research and development expenses).
Related Articles
HK Stock Market Move | ONEROBOTICS (06600) rises over 7%; three new embodied products ramp up simultaneously in the first half; the company is expected to further unlock platform-based synergies.
UBS: Initiates LI AUTO-W (02015) with "Buy" rating, target price HK$67
J.P. Morgan: Initiates KB LAMINATES (01888) with "Overweight" rating, target price HK$65
HK Stock Market Move | ONEROBOTICS (06600) rises over 7%; three new embodied products ramp up simultaneously in the first half; the company is expected to further unlock platform-based synergies.
UBS: Initiates LI AUTO-W (02015) with "Buy" rating, target price HK$67
J.P. Morgan: Initiates KB LAMINATES (01888) with "Overweight" rating, target price HK$65
